Top Markets
#1 Ontology Gas Ontology Gas +45.07%
#2 Anvil Anvil +19.32%
#3 ETHGas ETHGas +19.07%
#4 Status Status +18.81%
#5 The Black Bull The Black Bull +17.02%
#6 Geodnet Geodnet +16.47%
#7 Fake World Assets Fake World Assets +13.85%
#8 Derive Derive +10.68%
#9 Ontology Ontology +9.78%
#10 Gas Gas +9.27%
Coin of the day
Ontology Gas Ontology Gas
Настройки
Язык
Pусский
Валюта
USD
Тема
Singular Genomics Systems, Inc. Singular Genomics Systems, Inc.

Singular Genomics Systems, Inc.

OMIC
Ранг среди акций #25548
Singular Genomics Systems, Inc. is a life science technology firm focused on... Singular Genomics Systems, Inc. is a life science technology firm focused on creating advanced next-generation sequencing and multiomics solutions. The company aims to provide researchers and clinicians with innovative tools to accelerate scientific discovery and medical advancements. Among its core products is the G4 Instrument, a compact next-generation sequencer designed to deliver genetic sequencing results, supported by a selection of complementary consumable kits. Singular Genomics also offers the PX Integrated Solution, a versatile multiomics platform that consolidates single-cell analysis, spatial analysis, genomics, and proteomics into a single, unified instrument. To ensure broad compatibility for the G4, the company maintains strategic partnerships with entities like Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics for the validation of their library preparation kits. Additionally, a collaboration with the Broad Institute of MIT and Harvard enables the G4's integration with the Terra data platform. Established in 2016, Singular Genomics Systems, Inc. is headquartered in La Jolla, California.
Цена акции
$20.01
Последняя синхронизация: 2025-02-21
Рыночная капитализация
$48.36M
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля Singular Genomics Systems, Inc. (OMIC)

Категория

Healthcare
Выручка компании Singular Genomics Systems, Inc. (OMIC)
Выручка на Sep 2024 TTM: $2.67M
Согласно последним финансовым отчетам Singular Genomics Systems, Inc., текущая выручка компании (TTM) составляет $2.67M. В 2022 году компания получила выручку $765.00K больше, чем выручке в 2021 году, которая составила 0.00. Выручка — это общий доход, который компания получает от продажи товаров или услуг. В отличие от прибыли, расходы не вычитаются.
История выручки Singular Genomics Systems, Inc. с 2019 по 2026
Выручка на конец каждого года
Год Выручка Изменить
2026 (TTM) $2.67M -8.42%
2023 $2.91M 280.52%
2022 $765.00K 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
Выручка аналогичных компаний или конкурентов
Компания Выручка Разница в выручке Страна
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
 $11.03B 413,793.47%
US
EssilorLuxottica S.A. EssilorLuxottica S.A.
EssilorLuxottica S.A.
EL.PA
 $34.74B 1,302,846.52%
FR
HOYA Corporation HOYA Corporation
HOYA Corporation
7741.T
 - -
JP
Becton, Dickinson and Company Becton, Dickinson and Company
Becton, Dickinson and Company
BDX.US
 $20.84B 781,557.91%
US
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.SW
 - -
CH